Healthcare -
Biotechnology - NASDAQ - US
$ 6.74
2.43 %
$ 686 M
Market Cap
-14.98
P/E
TRVI - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative TRVI - Trevi Therapeutics, Inc.
12.1 M
LAST VALUE
9.81%
2 YEAR CAGR
10.70%
5 YEAR CAGR
0.00%
10 YEAR CAGR